Ultrasep ESD Pharm RP18 is a silica-based HPLC column with a wide-pore (300 Å) C18 bonded phase, specifically engineered for pharmaceutical and biochemical applications involving large molecules such as peptides, proteins, and oligonucleotides. The wide-pore structure provides excellent accessibility for biomacromolecules, while the C18 chemistry ensures strong hydrophobic retention and reproducible selectivity.
This pharmaceutical-grade bonding chemistry delivers robust performance, sharp peak shapes, and reproducibility under routine and demanding conditions. Ultrasep ESD Pharm RP18 is the reliable choice for pharmaceutical quality control, biopharmaceutical research, and proteomic studies.
Ultrasep ESD Pharm RP18 combines wide-pore silica with pharmaceutical-grade C18 chemistry – the dependable choice for robust biomolecular separations in pharmaceutical and biochemical laboratories.
Wide-pore silica stationary phase (300 Å) with pharmaceutical-grade C18 bonding
Strong hydrophobic retention for peptides, proteins, and biomolecules
Optimized for pharmaceutical and biotechnological separations
High reproducibility and robust column lifetime
Available particle size: 3 µm
Pharmaceutical quality control of protein and peptide formulations
Biopharmaceutical analysis of therapeutic biomolecules
Proteomic research involving peptides and proteins
Method development requiring robust wide-pore C18 selectivity
| Particle Size |
|
|---|---|
| Pore Size | 120 Å |
| Particle Type | |
| Separation Mode | |
| USP Code | |
| pH Range | 2 - 8 |
| Phase | Material Number |
|---|---|
| Ultrasep ESD Pharm RP18, 3 µm | ud13.p9. |